Q4 2023 Holdings
Filed 2024-02-14 | 53 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $135.7M | 1,625,000 | 12.7% |
| Sarepta Therapeutics Inc(SRPT)Call | COM | 803607100 | $67.5M | 700,000 | 6.3% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $64.0M | 1,800,000 | 6.0% |
| Apellis Pharmaceuticals Inc(APLS)Call | COM | 03753U106 | $59.9M | 1,000,000 | 5.6% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $56.9M | 950,000 | 5.3% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $55.2M | 145,000 | 5.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $54.4M | 4,383,875 | 5.1% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $50.6M | 1,200,000 | 4.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $43.6M | 1,070,058 | 4.1% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $38.2M | 1,275,000 | 3.6% |
| Rayzebio Inc | COM | 75525N107 | $35.3M | 568,173 | 3.3% |
| Ambrx Biopharma Inc | COM | 641871108 | $29.9M | 2,100,000 | 2.8% |
| Karuna Therapeutics Inc | COM | 48576A100 | $28.5M | 90,000 | 2.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $27.3M | 400,000 | 2.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $25.0M | 1,880,000 | 2.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $22.5M | 4,950,000 | 2.1% |
| Inhibrx Inc(INBXUSD)Call | COM | 45720L107 | $19.0M | 500,000 | 1.8% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $18.7M | 800,000 | 1.7% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $17.8M | 4,000,000 | 1.7% |
| Morphosys AG | SPONSORED ADS | 617760202 | $14.6M | 1,475,000 | 1.4% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $13.3M | 5,032,501 | 1.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $13.1M | 600,000 | 1.2% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $10.4M | 950,000 | 1.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $10.0M | 350,000 | 0.9% |
| Morphosys AGCall | SPONSORED ADS | 617760202 | $9.9M | 1,000,000 | 0.9% |
| Acelyrin Inc | COM | 00445A100 | $9.3M | 1,250,000 | 0.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $9.1M | 150,000 | 0.8% |
| Atyr Pharma Inc(ATYR) | COM NEW | 002120202 | $8.2M | 5,850,000 | 0.8% |
| Iovance Biotherapeutics Inc(IOVA)Call | COM | 462260100 | $8.1M | 1,000,000 | 0.8% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $8.1M | 1,200,000 | 0.8% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $7.9M | 2,900,000 | 0.7% |
| Zentalis Pharmaceuticals Inc(ZNTL)Call | COM | 98943L107 | $7.6M | 500,000 | 0.7% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $7.4M | 284,372 | 0.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $7.0M | 775,000 | 0.7% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $6.9M | 400,000 | 0.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.9M | 150,000 | 0.6% |
| Neumora Therapeutics Inc.(NMRA) | COM | 640979100 | $6.5M | 382,345 | 0.6% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $6.2M | 325,000 | 0.6% |
| Morphic Hldg Inc | COM | 61775R105 | $5.8M | 200,000 | 0.5% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $5.6M | 1,660,000 | 0.5% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $4.9M | 2,000,000 | 0.5% |
| Icosavax Inc | COM | 45114M109 | $4.7M | 300,000 | 0.4% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $4.4M | 600,000 | 0.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $4.4M | 500,000 | 0.4% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $4.2M | 307,076 | 0.4% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $4.2M | 544,960 | 0.4% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $3.8M | 100,000 | 0.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.2M | 150,000 | 0.3% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $2.6M | 150,000 | 0.2% |
| Delcath SYS Inc(DCTH) | COM NEW | 24661P807 | $1.2M | 300,000 | 0.1% |